Seres Therapeutics Inc (NASDAQ: MCRB) kicked off on Monday, up 29.89% from the previous trading day, before settling in for the closing price of $16.66. Over the past 52 weeks, MCRB has traded in a range of $6.53-$24.67.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 5.33%. With a float of $6.64 million, this company’s outstanding shares have now reached $8.76 million.
Seres Therapeutics Inc (MCRB) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Seres Therapeutics Inc is 26.65%, while institutional ownership is 10.72%. The most recent insider transaction that took place on Aug 18 ’25, was worth 3,613. In this transaction Director of this company sold 217 shares at a rate of $16.65, taking the stock ownership to the 10,609 shares. Before that another transaction happened on Aug 18 ’25, when Company’s insider sold 76 for $16.65, making the entire transaction worth $1,265. This insider now owns 7,455 shares in total.
Seres Therapeutics Inc (MCRB) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -2.2 earnings per share (EPS), higher than consensus estimate (set at -3.99) by 1.79. Wall Street market experts anticipate that the next fiscal year will bring earnings of -2.71 per share during the current fiscal year.
Seres Therapeutics Inc (NASDAQ: MCRB) Trading Performance Indicators
Take a look at Seres Therapeutics Inc’s (MCRB) current performance indicators. Last quarter, stock had a quick ratio of 2.30. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 559.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.61, a number that is poised to hit -2.11 in the next quarter and is forecasted to reach -8.97 in one year’s time.
Technical Analysis of Seres Therapeutics Inc (MCRB)
The latest stats from [Seres Therapeutics Inc, MCRB] show that its last 5-days average volume of 0.23 million was superior to 0.12 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 91.39%.
During the past 100 days, Seres Therapeutics Inc’s (MCRB) raw stochastic average was set at 80.81%, which indicates a significant decrease from 98.13% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.46 in the past 14 days, which was lower than the 1.50 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.74, while its 200-day Moving Average is $13.88. Now, the first resistance to watch is $23.20. This is followed by the second major resistance level at $24.77. The third major resistance level sits at $27.72. If the price goes on to break the first support level at $18.69, it is likely to go to the next support level at $15.74. Assuming the price breaks the second support level, the third support level stands at $14.17.
Seres Therapeutics Inc (NASDAQ: MCRB) Key Stats
The company with the Market Capitalisation of 195.76 million has total of 9,047K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of 140 K annual income. Company’s last quarter sales were recorded 350 K and last quarter income was 8,200 K.
